Abitare In Spa (ABT) Notizie

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
11/04/2005	20:00	PR Newswire (US)	Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity list	BIT:ABT
05/04/2005	14:00	PR Newswire (US)	Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They Need	BIT:ABT
11/02/2005	21:12	PR Newswire (US)	FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate Can	BIT:ABT
25/01/2005	16:00	PR Newswire (US)	FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder Cancer	BIT:ABT
15/12/2004	17:55	PR Newswire (US)	TAP Submits New Drug Application for Febuxostat for the Management of Hyperuricemia in Chronic Gout	BIT:ABT
01/11/2004	17:24	PR Newswire (US)	Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through S	BIT:ABT
01/11/2004	16:00	PR Newswire (US)	/C O R R E C T I O N -- Abbott Laboratories/	BIT:ABT
28/10/2004	20:00	PR Newswire (US)	Superstar Patti LaBelle Encourages Americans to Manage Diabetes 365 Days a Year	BIT:ABT
15/09/2004	17:00	PR Newswire (US)	Abbott's On-Site Child Care Center Recognized Amongst the Country's Best	BIT:ABT
27/07/2004	17:00	PR Newswire (US)	Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A Virus	BIT:ABT
14/07/2004	23:14	PR Newswire (US)	U.S. District Court Dismisses Claims Against Abbott Laboratories' Anti-Obesity Medication Meridia(R) (Sibutramine HCL Monohydrat	BIT:ABT
14/07/2004	15:30	PR Newswire (US)	Kaletra(R) (lopinavir/ritonavir) Based Regimens Demonstrate Favorable Resistance in Clinical Trials	BIT:ABT
24/06/2004	05:08	PR Newswire (US)	U.S. Food and Drug Administration (FDA) Denies Abbott's Citizen Petition Regarding Levothyroxine Sodium Products	BIT:ABT
22/06/2004	16:00	PR Newswire (US)	New Campaign Aims to Inspire People With Diabetes to Experience 'Diabetes Freedom'	BIT:ABT
11/06/2004	02:24	PR Newswire (US)	Abbott Laboratories' Statement Regarding FDA'S DDMAC Letter on Norvir(R) (Ritonavir Capsules) Materials	BIT:ABT
10/06/2004	15:00	PR Newswire (US)	ReAct Study Shows Abbott's Humira(R) (Adalimumab) Significantly Reduces Signs and Symptoms in Patients Battling Rheumatoid Arthr	BIT:ABT
07/06/2004	16:01	PR Newswire (US)	Abbott and Protein Design Labs Announce Broad, Long-Term Collaboration for Humanized Therapeutic Antibodies	BIT:ABT
06/06/2004	00:30	PR Newswire (US)	Meta-Analysis Results Presented at ASCO Show Statistically Significant Delay in Time to Disease Progression for Advanced Prostat	BIT:ABT
01/06/2004	16:30	PR Newswire (US)	Abbott Laboratories Introduces 10 Clinical Chemistry Tests	BIT:ABT
27/05/2004	16:30	PR Newswire (US)	Abbott Laboratories' Zemplar(R) (Paricalcitol Injection) Receives FDA Approval for Pediatric Use	BIT:ABT
26/05/2004	20:00	PR Newswire (US)	Data Demonstrate Impact of Weight Loss With Sibutramine on Cardiovascular Risk Factors for Obese Patients	BIT:ABT
14/05/2004	01:37	PR Newswire (US)	Abbott Laboratories to Present at Banc of America Securities Health Care Conference	BIT:ABT
06/05/2004	13:00	PR Newswire (US)	Abbott Laboratories Receives Positive Opinion for HUMIRA(R) Rheumatoid Arthritis Label Extension From European Medicines Evaluat	BIT:ABT
13/04/2004	19:20	PR Newswire (US)	Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients	BIT:ABT
12/04/2004	15:06	PR Newswire (US)	Abbott Laboratories Declares Special Dividend Distribution of Hospira Stock	BIT:ABT
22/03/2004	15:00	PR Newswire (US)	Study Suggests That Treatment for Women With Late-Stage Breast Cancer Is More Effective and Less Costly When FISH Diagnostic Tec	BIT:ABT
05/03/2004	15:44	PR Newswire (US)	Abbott and Seradyn Announce U.S. Clearance for Hemoglobin A(1C) (HbA(1C)) Test For Diabetes	BIT:ABT
01/03/2004	17:00	PR Newswire (US)	Abbott and Europroteome Announce Research Collaboration to Develop Diagnostic Tests for Breast Cancer	BIT:ABT
27/02/2004	16:00	PR Newswire (US)	Abbott Scholar Award in Rheumatology Given to Promising Researchers	BIT:ABT
12/02/2004	14:30	PR Newswire (US)	New Data Suggest Potential for Once-Daily Dosing Regimen of Kaletra(R) (Lopinavir/Ritonavir) in HIV Treatment-Naive Patients	BIT:ABT

ABT

Abitare In (ABT)

News di Agenzia

La tua Cronologia

Più Attivi

Toplist

ABT

Abitare In (ABT)

News di Agenzia

La tua Cronologia